Skip to main content

Advertisement

SpringerLink
Log in

Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey

  • Original Paper
  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

With cancer survivors now numbering over 13 million in the United States, and expected to continue to increase, it is important to consider the needs of this growing population. In the literature, one of the most common complaints by cancer survivors is perceived cognitive dysfunction. Since the preponderance of the research has focused on breast cancer survivors, the purpose of the present study was to explore the prevalence and correlates of perceived cognitive dysfunction in a large sample of cancer survivors with representation across a wide range of different types of cancer.

Methods

A sample of 3108 post-treatment cancer survivors completed the 2010 LIVESTRONG survey as part of a larger study of cancer survivorship. Respondents completed standardized questions regarding current and past perceived cognitive dysfunction, as well as depressive symptoms, and demographic and medical variables.

Results

Current perceived cognitive dysfunction was reported by nearly half of respondents (45.7 %), across a wide range of cancer types, with the highest prevalence among survivors of central nervous system cancers. Receiving chemotherapy and current report of depressive symptoms were both strongly associated with current perceived cognitive dysfunction.

Conclusion

These findings contribute to a growing appreciation of the high prevalence of perceived cognitive dysfunction in survivors of a wide range of cancer types and the potential interactive effect of concurrent symptoms of depression. These findings highlight a need to develop more effective means of preventing or reducing cognitive dysfunction in cancer survivors.

Implications for Cancer Survivors

Perceived cognitive dysfunction was reported in a wide range of cancer survivors. The potential interactive effect of symptoms of depression suggests the need to develop interventions targeting both cognitive dysfunction and depression to achieve improvements in cognitive functioning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cancer facts and figures 2014. Atlanta: American Cancer Society; 2014.

  2. de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomark Prev. 2013;22(4):561–70.

    Article  Google Scholar 

  3. Beckjord EB, Reynolds KA, van Londen GJ, Burns R, Singh R, Arvey SR, et al. Population-level trends in posttreatment cancer survivors’ concerns and associated receipt of care: results from the 2006 and 2010 LIVESTRONG surveys. J Psychosoc Oncol. 2014;32(2):125–51.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G. Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsych Soc. 2009;15(6):951–62.

    Article  Google Scholar 

  5. Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB. Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer. 2009;115(8):1776–83.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol: Off J Am Soc Clin Oncol. 2000;18(14):2695–701.

    CAS  Google Scholar 

  7. Hurria A, Somlo G, Ahles T. Renaming “chemobrain”. Cancer Investig. 2007;25(6):373–7.

    Article  Google Scholar 

  8. Joly F, Rigal O, Noal S, Giffard B. Cognitive dysfunction and cancer: which consequences in terms of disease management? Psycho-Oncology. 2011;20(12):1251–8.

    Article  PubMed  Google Scholar 

  9. Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology. 2009;18(2):134–43.

    Article  PubMed  Google Scholar 

  10. Agrawal K, Onami S, Mortimer JE, Pal SK. Cognitive changes associated with endocrine therapy for breast cancer. Maturitas. 2010;67(3):209–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ganz PA, Petersen L, Castellon SA, Bower JE, Silverman DH, Cole SW, et al. Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study. J Clin Oncol: Off J Am Soc Clin Oncol. 2014;32(31):3559–67.

    Article  Google Scholar 

  12. Mitsiades N, Correa D, Gross CP, Hurria A, Slovin SF. Cognitive effects of hormonal therapy in older adults. Semin Oncol. 2008;35(6):569–81.

    Article  CAS  PubMed  Google Scholar 

  13. Myers JS. Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum. 2012;39(1):E31–40.

    Article  PubMed  Google Scholar 

  14. Pullens MJ, De Vries J, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology. 2010;19(11):1127–38.

    Article  PubMed  Google Scholar 

  15. Hermelink K, Kuchenhoff H, Untch M, Bauerfeind I, Lux MP, Buhner M, et al. Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psycho-Oncology. 2010;19(12):1321–8.

    Article  PubMed  Google Scholar 

  16. Lindner OC, Phillips B, McCabe MG, Mayes A, Wearden A, Varese F, et al. A meta-analysis of cognitive impairment following adult cancer chemotherapy. Neuropsychology. 2014;28(5):726–40.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Von Ah D, Tallman EF. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. J Pain Symptom Manag. 2015;49(4):697–706.

    Article  Google Scholar 

  18. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38(7):926–34.

    Article  PubMed  Google Scholar 

  19. Biglia N, Bounous VE, Malabaila A, Palmisano D, Torta DM, D’Alonzo M, et al. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Europ J Cancer Care. 2012;21(4):485–92.

    Article  CAS  Google Scholar 

  20. Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv: Res Pract. 2009;3(4):223–32.

    Article  Google Scholar 

  21. Von Ah D, Russell KM, Storniolo AM, Carpenter JS. Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncol Nurs Forum. 2009;36(3):326–36.

    Article  Google Scholar 

  22. Cruzado JA, Lopez-Santiago S, Martinez-Marin V, Jose-Moreno G, Custodio AB, Feliu J. Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer. 2014;22(7):1815–23.

    Article  Google Scholar 

  23. Wefel JS, Vidrine DJ, Marani SK, Swartz RJ, Veramonti TL, Meyers CA, et al. A prospective study of cognitive function in men with non-seminomatous germ cell tumors. Psycho-Oncology. 2014;23(6):626–33.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JB, et al. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol: Off J Am Soc Clin Oncol. 2011;29(17):2397–404.

    Article  Google Scholar 

  25. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Experiment Clin Cancer Res: CR. 2008;27:32.

    Article  Google Scholar 

  26. Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL, et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer. 2006;107(12):2924–31.

    Article  PubMed  Google Scholar 

  27. Rechis R, Reynolds KA, Beckjord EB, Nutt S, Burns RM, Schaefer JS. “I learned to live with it” is not enough: challenges reported by post-treatment cancer survivors in the LIVESTRONG surveys. Austin: LIVESTRONG; 2011.

    Google Scholar 

  28. Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver CS. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res: Int J Qual Life Asp treat, Care Rehab. 2005;14(4):1007–23.

    Article  Google Scholar 

  29. Hudson MM, Landier W, Ganz PA. Impact of survivorship-based research on defining clinical care guidelines. Cancer Epidemiol, Biomark Prevent: Public Am Assoc Cancer Res, Cospons Am Soc Prevent Oncol. 2011;20(10):2085–92.

    Article  Google Scholar 

  30. Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer. 2006;94(6):828–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Meskal I, Gehring K, van der Linden SD, Rutten GJ, Sitskoorn MM. Cognitive improvement in meningioma patients after surgery: clinical relevance of computerized testing. J Neurooncol. 2015;121(3):617–25.

    Article  PubMed  Google Scholar 

  32. van Nieuwenhuizen D, Ambachtsheer N, Heimans JJ, Reijneveld JC, Peerdeman SM, Klein M. Neurocognitive functioning and health-related quality of life in patients with radiologically suspected meningiomas. J Neurooncol. 2013;113(3):433–40.

    Article  PubMed  Google Scholar 

  33. Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenite DG, Aaronson NK, Taphoorn MJ, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54(4):514–20.

    Article  PubMed  Google Scholar 

  34. Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):699–708.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lange M, Rigal O, Clarisse B, Giffard B, Sevin E, Barillet M, et al. Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists. Cancer Treat Rev. 2014;40(6):810–7.

    Article  PubMed  Google Scholar 

  36. Lange M, Giffard B, Noal S, Rigal O, Kurtz JE, Heutte N, et al. Baseline cognitive functions among elderly patients with localised breast cancer. Europ J Cancer. 2014.

  37. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28(29):4434–40.

    Article  Google Scholar 

  38. Mandelblatt JS, Hurria A, McDonald BC, Saykin AJ, Stern RA, VanMeter JW, et al. Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol. 2013;40(6):709–25.

    Article  PubMed  Google Scholar 

  39. McDonald BC, Conroy SK, Smith DJ, West JD, Saykin AJ. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun. 2013;30(Suppl):S117–25.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DH, Geist C, et al. Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun. 2013;30(Suppl):S99–108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. National Institutes of Health Consensus Development P. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst Monograph. 2001(30):5–15.

  42. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59(1):61–71.

    Article  PubMed  Google Scholar 

  43. Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, et al. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28(8):1294–300.

    Article  CAS  Google Scholar 

  44. Fan HG, Houede-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol: Off J Am Soc Clin Oncol. 2005;23(31):8025–32.

    Article  Google Scholar 

  45. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer. 2004;101(3):466–75.

    Article  PubMed  Google Scholar 

  46. Askren M, Jung M, Berman M, Zhang M, Therrien B, Peltier S, et al. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation. Breast Cancer Res Tr. 2014;147(2):445–55.

    Article  CAS  Google Scholar 

  47. Schagen SB, Klein M, Reijneveld JC, Brain E, Deprez S, Joly F, et al. Monitoring and optimising cognitive function in cancer patients: present knowledge and future directions. Eur J Cancer Suppl. 2014;12(1):29–40.

    Article  CAS  Google Scholar 

  48. Schilder CMT, Seynaeve C, Linn SC, Boogerd W, Beex LVAM, Gundy CM, et al. Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Crit Rev Oncol/Hematol. 2010;76(2):133–41.

    Article  CAS  Google Scholar 

  49. Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosc Rep. 2012;12(3):267–75.

    Article  CAS  Google Scholar 

  50. Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull. 2013;139(1):81–132.

    Article  PubMed  PubMed Central  Google Scholar 

  51. O’Farrell E, MacKenzie J, Collins B. Clearing the air: a review of our current understanding of “chemo fog”. Curr Oncol Rep. 2013;15(3):260–9.

    Article  PubMed  Google Scholar 

  52. Spoletini I, Gianni W, Repetto L, Bria P, Caltagirone C, Bossu P, et al. Depression and cancer: an unexplored and unresolved emergent issue in elderly patients. Crit Rev Oncol/Hematol. 2008;65(2):143–55.

    Article  Google Scholar 

  53. Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer. 2006;94(3):372–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Hopko DR, Bell JL, Armento MEA, Robertson SMC, Hunt MK, Wolf NJ, et al. The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol. 2007;26(1):31–51.

    Article  Google Scholar 

  55. van Heugten C, Wolters Gregório G, Wade D. Evidence-based cognitive rehabilitation after acquired brain injury: a systematic review of content of treatment. Neuropsychologic Rehab. 2012;22(5):653–73.

    Article  Google Scholar 

  56. Carney N, Chesnut RM, Maynard H, Mann NC, Patterson P, Helfand M. Effect of cognitive rehabilitation on outcomes for persons with traumatic brain injury: a systematic review. J Head Trauma Rehabil. 1999;14(3):277–307.

    Article  CAS  PubMed  Google Scholar 

  57. Zelinski EM, Spina LM, Yaffe K, Ruff R, Kennison RF, Mahncke HW, et al. Improvement in memory with plasticity-based adaptive cognitive training: results of the 3-month follow-up. J Am Geriatr Soc. 2011;59(2):258–65.

    Article  PubMed  Google Scholar 

  58. Kesler S, Hadi Hosseini SM, Heckler C, Janelsins M, Palesh O, Mustian K, et al. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer. 2013;13(4):299–306.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Kesler SR, Lacayo NJ, Jo B. A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injury. Brain Injur: [BI]. 2011;25(1):101–12.

    Article  Google Scholar 

  60. Finn M, McDonald S. Computerised cognitive training for older persons with mild cognitive impairment: a pilot study using a randomised controlled trial design. Brain Impair. 2011;12(03):187–99.

    Article  Google Scholar 

  61. Gehring K, Patwardhan S, Collins R, Groves M, Etzel C, Meyers C, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neuro-Oncol. 2012;107(1):165–74.

    Article  CAS  Google Scholar 

  62. Gehring K, Roukema J, Sitskoorn M. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Rev Anticancer Ther. 2012;12(2):255–69.

    Article  CAS  PubMed  Google Scholar 

  63. Mackin RS, Nelson JC, Delucchi K, Raue P, Byers A, Barnes D, et al. Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunction. Am J Geriatr Psychiatr: Off J Am Assoc Geriatr Psychiatr. 2013.

  64. Culang ME, Sneed JR, Keilp JG, Rutherford BR, Pelton GH, Devanand DP, et al. Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatr: Off J Am Assoc Geriatr Psychiatr. 2009;17(10):881–8.

    Article  Google Scholar 

  65. Law LL, Barnett F, Yau MK, Gray MA. Effects of combined cognitive and exercise interventions on cognition in older adults with and without cognitive impairment: a systematic review. Ageing Res Rev. 2014;15:61–75.

    Article  PubMed  Google Scholar 

  66. Barnes DE, Santos-Modesitt W, Poelke G, Kramer AF, Castro C, Middleton LE, et al. The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults. JAMA Int Med. 2013;173(9):797–804.

    Article  Google Scholar 

  67. Von Ah D, Carpenter JS, Saykin A, Monahan P, Wu JW, Yu MG, et al. Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Tr. 2012;135(3):799–809.

    Article  Google Scholar 

  68. Hermelink K, Kuchenhoff H, Untch M, Bauerfeind I, Lux MP, Buhner M, et al. Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psycho-Oncology. 2010;19(12):1321–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by funding from the LIVESTRONG Foundation.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. University of Pittsburgh, Pittsburgh, PA, USA

    John E. Schmidt, Ellen Beckjord, Dana H. Bovbjerg, Carissa A. Low, Donna M. Posluszny, Amy E. Lowery & Mary Amanda Dew

  2. Research and Evaluation, LIVESTRONG Foundation, Austin, TX, USA

    Stephanie Nutt, Sarah R. Arvey & Ruth Rechis

  3. Walter Reed National Military Medical Center, 8955 Wood Road, Bethesda, MD, 20889, USA

    John E. Schmidt

Authors
  1. John E. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ellen Beckjord
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dana H. Bovbjerg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carissa A. Low
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Donna M. Posluszny
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Amy E. Lowery
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mary Amanda Dew
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Stephanie Nutt
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sarah R. Arvey
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ruth Rechis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John E. Schmidt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmidt, J.E., Beckjord, E., Bovbjerg, D.H. et al. Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv 10, 302–311 (2016). https://doi.org/10.1007/s11764-015-0476-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-015-0476-5

Keywords

Search

Navigation